{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04808505",
            "orgStudyIdInfo": {
                "id": "ATB200-08"
            },
            "organization": {
                "fullName": "Amicus Therapeutics",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study to Evaluate the Safety, Efficacy, PK, PD and Immunogenicity of Cipaglucosidase Alfa/Miglustat in IOPD Subjects Aged 0 to <18",
            "officialTitle": "An Open-label Study to Evaluate the Safety, Efficacy, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Cipaglucosidase Alfa/Miglustat in Both ERT-experienced and ERT-na\u00efve Pediatric Subjects With Infantile-onset Pompe Disease Aged 0 to < 18 Years",
            "acronym": "ROSSELLA",
            "therapeuticArea": [
                "Pediatrics"
            ],
            "study": "a-study-to-evaluate-the-safety-efficacy-pk-pd-and-immunogenicity-of-cipaglucosidase-alfa-miglustat-in-iopd-subjects-aged-to"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-08",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": true,
                "nctId": "NCT03865836",
                "statusForNctId": "AVAILABLE"
            },
            "startDateStruct": {
                "date": "2023-07-18",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2027-04",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-04",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-03-10",
            "studyFirstSubmitQcDate": "2021-03-17",
            "studyFirstPostDateStruct": {
                "date": "2021-03-22",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-03",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-06",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Amicus Therapeutics",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a Phase 3, open-label, multicenter study to evaluate the safety, efficacy, PK, PD, and immunogenicity of cipaglucosidase alfa/miglustat treatment in ERT-experienced and ERT-na\u00efve pediatric subjects with IOPD."
        },
        "conditionsModule": {
            "conditions": [
                "Glycogen Storage Disease Type II Infantile Onset"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 36,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Cohort 1: Cipaglucosidase Alfa/Miglustat in ERT-experienced pediatric IOPD subjects",
                    "type": "EXPERIMENTAL",
                    "description": "Pediatric IOPD subjects 6 months to \\<18 years experiencing clinical decline",
                    "interventionNames": [
                        "Biological: Cipaglucosidase alfa",
                        "Drug: Miglustat"
                    ]
                },
                {
                    "label": "Cohort 2: Cipaglucosidase Alfa/Miglustat in ERT-na\u00efve pediatric IOPD subjects",
                    "type": "EXPERIMENTAL",
                    "description": "Pediatric IOPD subjects \\<6 months",
                    "interventionNames": [
                        "Biological: Cipaglucosidase alfa",
                        "Drug: Miglustat"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BIOLOGICAL",
                    "name": "Cipaglucosidase alfa",
                    "description": "Sterile lyophilized powder intravenous (IV) infusion",
                    "armGroupLabels": [
                        "Cohort 1: Cipaglucosidase Alfa/Miglustat in ERT-experienced pediatric IOPD subjects",
                        "Cohort 2: Cipaglucosidase Alfa/Miglustat in ERT-na\u00efve pediatric IOPD subjects"
                    ],
                    "otherNames": [
                        "ATB200"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Miglustat",
                    "description": "65 mg oral capsules",
                    "armGroupLabels": [
                        "Cohort 1: Cipaglucosidase Alfa/Miglustat in ERT-experienced pediatric IOPD subjects",
                        "Cohort 2: Cipaglucosidase Alfa/Miglustat in ERT-na\u00efve pediatric IOPD subjects"
                    ],
                    "otherNames": [
                        "AT2221"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Proportion of subjects with infusion-associated reactions (IARs)",
                    "timeFrame": "104 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\nCohort 1:\n\n1. Male or female subjects who are aged 6 months to \\< 18 years on Day 1\n2. Subject must have documentation of IOPD genotype\n3. Subject must have had hypertrophic cardiomyopathy at the time of diagnosis\n4. Subject must have received ERT for at least 6 months immediately before enrollment. For subjects whose ERT dosage has been modified, the subject must have been on the modified dosage and regimen for at least 3 months before enrollment\n5. Subjects aged \u2265 12 to \\< 18 years must perform one valid 6-minute walk test (6MWT) (\u2265 75 meters) at screening; Subjects aged \u2265 5 to \\< 12 years must perform one valid 6MWT (\u2265 40 meters) at screening; Subjects aged 18 months to \\< 5 years must be ambulatory and assessed to be likely to be able to perform 6MWT (\u2265 40 meters) when they turn 5 years old\n6. Subjects must have experienced a clinical decline on their current rhGAA dose and frequency\n\nCohort 2:\n\n1. Male or female subjects who are aged 0 to \\<6 months at Day 1\n2. Subject must have documentation of IOPD genotype\n3. Subject must have had hypertrophic cardiomyopathy at the time of diagnosis\n4. Subject is ERT-na\u00efve\n\nLong-term Extension (Cohort 1 or Cohort 2):\n\n1. Subject must have, in the opinion of the investigator, benefited from therapy with cipaglucosidase alfa/miglustat during the 104-week primary treatment period with no significant safety concerns.\n\nExclusion Criteria:\n\nCohort 1 and Cohort 2, unless specified\n\n1. Subject requires invasive ventilation (eg, tracheostomy)\n2. Subject is CRIM negative and has not received prophylactic immunomodulation (Cohort 1); Subject is CRIM negative and will not be receiving prophylactic immunomodulation (Cohort 2)\n3. Subject has a history of life-threatening IARs/hypersensitivity (eg, anaphylaxis and severe cutaneous reactions) to ERT (eg, alglucosidase alfa, cipaglucosidase alfa, miglustat) or other iminosugars, or to any of the excipients, where rechallenge was unsuccessful\n4. Subject has prior history of illness or condition known to affect motor function\n5. Female subject is pregnant (or intends to get pregnant) or breastfeeding at screening (Cohort 1)",
            "healthyVolunteers": false,
            "sex": "ALL",
            "maximumAge": "17 Years",
            "stdAges": [
                "CHILD"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "For Site",
                    "role": "CONTACT",
                    "phone": "215-921-7600",
                    "email": "PompeSiteInfo@amicusrx.com"
                },
                {
                    "name": "For Patient",
                    "role": "CONTACT",
                    "phone": "215-921-7600",
                    "email": "patientadvocacy@amicusrx.com"
                }
            ],
            "locations": [
                {
                    "facility": "University of Florida Clinical Research Center",
                    "status": "RECRUITING",
                    "city": "Gainesville",
                    "state": "Florida",
                    "zip": "32610",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.65163,
                        "lon": -82.32483
                    }
                },
                {
                    "facility": "The Emory Clinic",
                    "status": "RECRUITING",
                    "city": "Atlanta",
                    "state": "Georgia",
                    "zip": "30322",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.749,
                        "lon": -84.38798
                    }
                },
                {
                    "facility": "Duke University Early Phase Research Unit",
                    "status": "RECRUITING",
                    "city": "Durham",
                    "state": "North Carolina",
                    "zip": "27710",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 35.99403,
                        "lon": -78.89862
                    }
                },
                {
                    "facility": "University of Utah, Clinical and Translational Sciences Institute",
                    "status": "RECRUITING",
                    "city": "Salt Lake City",
                    "state": "Utah",
                    "zip": "84108",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.76078,
                        "lon": -111.89105
                    }
                },
                {
                    "facility": "H\u00f4pital Raymond Poincar\u00e9, Neurologie et r\u00e9animation p\u00e9diatriques",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Garches",
                    "zip": "92380",
                    "country": "France",
                    "geoPoint": {
                        "lat": 48.84226,
                        "lon": 2.18232
                    }
                },
                {
                    "facility": "Universit\u00e4tsklinikum Gie\u00dfen und Marburg GmbH, Zentrum fur Kinderheilkunde und Jugendmedizin Abteilung fur Kinderneurologic, Sozialpadiatric und Epileptologie",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Gie\u00dfen",
                    "zip": "35392",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 50.58727,
                        "lon": 8.67554
                    }
                },
                {
                    "facility": "SphinCS GmbH",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Hochheim",
                    "zip": "65239",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 50.36667,
                        "lon": 10.45
                    }
                },
                {
                    "facility": "Universit\u00e4tsklinikum M\u00fcnster Klinik f\u00fcr Kinder- und Jugendmedizin Albert-Schweitzer-Campus 1",
                    "status": "NOT_YET_RECRUITING",
                    "city": "M\u00fcnster",
                    "zip": "48149",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 51.96236,
                        "lon": 7.62571
                    }
                },
                {
                    "facility": "AOU Federico II",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Naples",
                    "zip": "80131",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 40.85216,
                        "lon": 14.26811
                    }
                },
                {
                    "facility": "Azienda Ospedale Inherited Metabolic Disease Department",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Padova",
                    "zip": "35128",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 45.40797,
                        "lon": 11.88586
                    }
                },
                {
                    "facility": "National Taiwan University Hospital",
                    "status": "WITHDRAWN",
                    "city": "Taipei",
                    "zip": "100",
                    "country": "Taiwan",
                    "geoPoint": {
                        "lat": 25.04776,
                        "lon": 121.53185
                    }
                },
                {
                    "facility": "Great Ormond Street Hospital for Children NHS Foundation Trust",
                    "status": "NOT_YET_RECRUITING",
                    "city": "London",
                    "zip": "WC1N3JH",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 51.50853,
                        "lon": -0.12574
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000006009",
                    "term": "Glycogen Storage Disease Type II"
                },
                {
                    "id": "D000006008",
                    "term": "Glycogen Storage Disease"
                }
            ],
            "ancestors": [
                {
                    "id": "D000002239",
                    "term": "Carbohydrate Metabolism, Inborn Errors"
                },
                {
                    "id": "D000008661",
                    "term": "Metabolism, Inborn Errors"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                },
                {
                    "id": "D000020140",
                    "term": "Lysosomal Storage Diseases, Nervous System"
                },
                {
                    "id": "D000020739",
                    "term": "Brain Diseases, Metabolic, Inborn"
                },
                {
                    "id": "D000001928",
                    "term": "Brain Diseases, Metabolic"
                },
                {
                    "id": "D000001927",
                    "term": "Brain Diseases"
                },
                {
                    "id": "D000002493",
                    "term": "Central Nervous System Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000016464",
                    "term": "Lysosomal Storage Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M9114",
                    "name": "Glycogen Storage Disease",
                    "asFound": "Glycogen Storage Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9115",
                    "name": "Glycogen Storage Disease Type II",
                    "asFound": "Glycogen Storage Disease Type II",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11641",
                    "name": "Metabolism, Inborn Errors",
                    "relevance": "LOW"
                },
                {
                    "id": "M5498",
                    "name": "Carbohydrate Metabolism, Inborn Errors",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M18871",
                    "name": "Lysosomal Storage Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5204",
                    "name": "Brain Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5205",
                    "name": "Brain Diseases, Metabolic",
                    "relevance": "LOW"
                },
                {
                    "id": "M22498",
                    "name": "Brain Diseases, Metabolic, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "M5742",
                    "name": "Central Nervous System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T2562",
                    "name": "Glycogen Storage Disease Type 2",
                    "asFound": "Glycogen Storage Disease Type II",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000059896",
                    "term": "Miglustat"
                }
            ],
            "ancestors": [
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000019380",
                    "term": "Anti-HIV Agents"
                },
                {
                    "id": "D000044966",
                    "term": "Anti-Retroviral Agents"
                },
                {
                    "id": "D000000998",
                    "term": "Antiviral Agents"
                },
                {
                    "id": "D000000890",
                    "term": "Anti-Infective Agents"
                },
                {
                    "id": "D000065089",
                    "term": "Glycoside Hydrolase Inhibitors"
                },
                {
                    "id": "D000007004",
                    "term": "Hypoglycemic Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M351060",
                    "name": "Miglustat",
                    "asFound": "Ink",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M21350",
                    "name": "Anti-HIV Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M25428",
                    "name": "Anti-Retroviral Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4314",
                    "name": "Antiviral Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4214",
                    "name": "Anti-Infective Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M30447",
                    "name": "Glycoside Hydrolase Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M5557",
                    "name": "Cardiac Glycosides",
                    "relevance": "LOW"
                },
                {
                    "id": "M10054",
                    "name": "Hypoglycemic Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Hypo",
                    "name": "Hypoglycemic Agents"
                },
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "AnArAg",
                    "name": "Anti-Arrhythmia Agents"
                },
                {
                    "abbrev": "CaAg",
                    "name": "Cardiotonic Agents"
                }
            ]
        }
    },
    "hasResults": false
}